stdClass Object
(
    [id] => 15876
    [paper_index] => 202505-02-021448
    [title] => A COMPREHENSIVE REVIEW OF DRUG-DRUG INTERACTIONS BETWEEN ASTHMA MEDICATIONS AND BETA BLOCKERS: MECHANISMS, MANAGEMENT, AND CLINICAL CONSIDERATIONS
    [description] => 
    [author] => Miss Komal Waghmare, Mr. Laxman Rathod
    [googlescholar] => 
    [doi] => 
    [year] => 2025
    [month] => May
    [volume] => 10
    [issue] => 5
    [file] => fm/jpanel/upload/2025/May/202505-02-021448.pdf
    [abstract] => Asthma is a long-term inflammatory airway condition that frequently coexists with cardiovascular disorders, making treatment difficult, especially when beta blockers are required. By blockingβ2-adrenergic receptors, beta blockers—especially non-selective ones—may worsen asthma by decreasing the effectiveness of bronchodilators. Conversely, asthma drugs, particularlyβ2-agonists, may mitigate the beneficial effects of beta blockers on the heart. This study covers the causes, dangers, and evidence-based co-management techniques regarding the pharmacological and clinical interactions between beta blockers and asthma medications. This article provides physicians with a roadmap for navigating the intricate junction of respiratory and cardiovascular pharmacology, emphasizing pharmacodynamics, pharmacokinetics, and customized treatment.
    [keywords] => Asthma, Beta blockers, Drug-drug interactions, Bronchospasm, β2-agonists, Cardio selective beta blockers, ICS, Pharmacokinetics, Pharmacodynamics, Co-management.
    [doj] => 2025-05-09
    [hit] => 
    [status] => 
    [award_status] => P
    [orderr] => 13
    [journal_id] => 2
    [googlesearch_link] => 
    [edit_on] => 
    [is_status] => 1
    [journalname] => EPRA International Journal of Research & Development (IJRD)
    [short_code] => IJSR
    [eissn] =>  2455-7838 (Online)
    [pissn] => - -
    [home_page_wrapper] => images/products_image/2-n.png
)
Error fetching PDF file.